Revolution Medicines, Inc. (RVMD) Insider Trading

Over the last 3 months, RVMD insiders made 0 open-market buys and 20 sales, a net sale of -$25.6M (SEC Form 4). Over the last 6 months, 330 institutions increased and 232 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
20
Net (3m)
-$25.6M
Insider trades by month Buys Sells
Nov
Dec
Jan
Mar
Apr
May
Context3-month price +54.2%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
May 28, 2026Mancini Anthonyofficer: See RemarksSell421$154.82
May 28, 2026Mancini Anthonyofficer: See RemarksSell700$153.30
May 28, 2026Mancini Anthonyofficer: See RemarksSell2,000$154.06
May 28, 2026Mancini Anthonyofficer: See RemarksOption3,121$33.62
Apr 29, 2026Mancini Anthonyofficer: See RemarksSell1,049$132.88
Apr 29, 2026Mancini Anthonyofficer: See RemarksSell400$134.34
Apr 29, 2026Mancini Anthonyofficer: See RemarksOption3,120$33.62
Apr 29, 2026Mancini Anthonyofficer: See RemarksSell1,671$131.66
Apr 17, 2026GOLDSMITH MARK Adirector, officer: See RemarksOption96,756$4.73
Apr 17, 2026GOLDSMITH MARK Adirector, officer: See RemarksOption23,244$4.09
Apr 17, 2026GOLDSMITH MARK Adirector, officer: See RemarksSell120,000$150.09
Mar 26, 2026Mancini Anthonyofficer: See RemarksSell3,128$94.16
Mar 26, 2026Mancini Anthonyofficer: See RemarksSell21,086$95.49
Mar 26, 2026Mancini Anthonyofficer: See RemarksSell400$97.21
Mar 26, 2026Mancini Anthonyofficer: See RemarksSell1,800$93.22
Mar 26, 2026Mancini Anthonyofficer: See RemarksOption37,450$33.62
Mar 26, 2026Mancini Anthonyofficer: See RemarksSell11,036$96.43
Mar 19, 2026Cislini Jeffofficer: General CounselSell1,163$97.44
Mar 19, 2026GOLDSMITH MARK Adirector, officer: See RemarksSell12,871$99.48
Mar 19, 2026Kelsey Stephen Michaelofficer: See RemarksSell4,302$99.48
Mar 19, 2026Horn Margaret Aofficer: Chief Operating OfficerSell4,583$99.48
Mar 19, 2026Cislini Jeffofficer: General CounselSell1,795$99.48
Mar 19, 2026Wang Xiaolinofficer: See RemarksSell2,010$99.48
Mar 19, 2026Wei Linofficer: Chief Medical OfficerSell2,073$99.48
Mar 19, 2026Anders Jackofficer: Chief Financial OfficerSell2,753$99.48
Mar 3, 2026GOLDSMITH MARK Adirector, officer: See RemarksGrant128,600$102.02
Mar 3, 2026GOLDSMITH MARK Adirector, officer: See RemarksSell400$100.12
Mar 3, 2026GOLDSMITH MARK Adirector, officer: See RemarksSell1,700$101.47
Mar 3, 2026Anders Jackofficer: Chief Financial OfficerGrant20,200—
Mar 3, 2026GOLDSMITH MARK Adirector, officer: See RemarksSell3,620$100.73

Source: RVMD SEC Form 4 filings, latest May 28, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their RVMD positions over the last 6 months (SEC Form 13F).

Increased
330
New positions
262
Reduced
232
Sold out
71
Largest moves
InstitutionActionSharesFiled
VANGUARD GROUP INCIncreased16.7MJan 29, 2026
FARALLON CAPITAL MANAGEMENT LLCIncreased14.6MFeb 17, 2026
FARALLON CAPITAL MANAGEMENT LLCReduced14.6MFeb 17, 2026
FARALLON CAPITAL MANAGEMENT LLCReduced13.6MMay 15, 2026
JANUS HENDERSON GROUP PLCIncreased12.3MFeb 17, 2026
BLACKROCK, INC.Increased11.2MMay 13, 2026
JANUS HENDERSON GROUP PLCReduced9.8MMay 18, 2026
BAKER BROS. ADVISORS LPIncreased9.6MMay 15, 2026
BAKER BROS. ADVISORS LPUnchanged9.5MFeb 17, 2026
BLACKROCK, INC.Increased8.9MFeb 12, 2026
FMR LLCReduced8.6MFeb 17, 2026
FMR LLCReduced8.5MMay 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position8.4MMay 15, 2026
NEXTECH INVEST, LTD.Unchanged7.6MMay 15, 2026
NEXTECH INVEST, LTD.Unchanged7.6MFeb 17, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.

← Back to RVMD overview (price, financials, earnings)